MARATTO

article · International Journal of Science for Global Sustainability

Comparative Phytochemical Studies of Ficus Sycomorus, Khaya Senegalese, And Azadirachta Indica Leaves Extract

Abstract

The phytochemical content of three medicinal plants Ficus sycomorus, Khaya senegalensis, and Azadirachta indica which are considered as a major source of new antibiotics was determined. the goal of our research is to evaluate the phytochemicals of Ficus sycomorus, khaya senegalensis, and Azadirachta indica leaves extracts. The methanol, ethyl acetate and n-hexane, extracts of these plants were subjected to phytochemical test, the result of the phytochemical analysis for different solvent revealed the presence of Tannins, Alkaloids, and Flavonoids. Quantitative estimation of phytoconstituent revealed that saponins were present in great amounts in all the extracts screened, (p-value 0.005 less than the alpha 0.05) while Flavonoids, and Alkaloids were present in sufficient amounts with (p-value 0.000 less than the alpha 0.05). The results showed that all the plant samples were rich source of phytochemicals. it could be suggested that this plant has a potential as a source of therapeutic agents. this supports the traditional use of the plant in curing human diseases. It is therefore suggested that further studies be carried out using different solvents as well as to isolate, purify and identify the active compounds present in the extracts with a view to justifying these claims.

Research topics

  • Phytochemistry and biological activities of Ficus species
  • African Botany and Ecology Studies
  • Ethnobotanical and Medicinal Plants Studies

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.57233/ijsgs.v9i4.559

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.